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Abstract: Different strategies for the racemic or enantiospecific total syntheses of plant 
and mammalian 3,4-dibenzyltetrahydrofuran lignans are reviewed and compared. The 
multi-step approaches have various key step strategies: Diels–Alder reactions, Stobbe 
condensations, Michael additions, alkylations, nitrile oxide cycloadditions, radical 
cyclisations, dianion and oxidative couplings. 
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1. Introduction 
Phytoestrogens are plant derived compounds that may have estrogen-like actions in humans and 
animals. Lignans, together with the other main phytoestrogens—isoflavones, flavonoids and 
coumestans—are polyphenols and have structural similarity to the natural and synthetic steroid 
estrogens. Thus, depending on their concentration and other factors, they can act either like weak 
estrogens by binding to the estrogen receptors on cell membranes, or as estrogen antagonists by 
preventing estrogens from binding to the receptors [1]. 
After the first mammalian lignans enterolactone and enterodiol, intestinal metabolites of plant 
lignans, were reported at the beginning of 1980s [2,3], the relevance of lignans for human health has 
been under active and extensive study. In the recent years new mammalian lignans have been found and 
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identified or tentatively identified, e.g., trans-3,4-dibenzyltetrahydrofuran type lignans (9,9'-epoxylignanes) 
enterofuran (1) and anhydrosecoisolariciresinol (2) (Figure 1) [4–7]. 
Tetrahydrofuran-type lignans found in plants (Figure 1) are used both in Japanese folk medicine and 
in traditional Chinese medicine [8]. They have shown antioxidant [9], antibacterial [10] and 
insecticidal [11] activity and tumor-inhibitory properties [12]. Recent studies, in animals and humans, 
have suggested that a high consumption of phytoestrogens may reduce the risk of breast cancer. It is 
postulated that phytoestrogens may affect cancer incidence by altering production and metabolism of 
steroid hormones and their action at the cellular level [13]. Both the mammalian lignan enterofuran (1) 
and especially the plant lignan anhydrosecoisolariciresinol ((−)-2) have shown high affinity to human 
sex hormone binding globulin (SHBG) [14,15], which is the major plasma sex hormone transport 
protein with a high affinity to bind androgens and estrogens. (−)-2 was able to completely prevent 
dihydrotestosterone from binding to the SHBG under the conditions tested. 
Since the possible role of lignans and their metabolites in preventing hormone-dependent diseases 
has been recognized [16], synthetic methods for authentic standards as well as isotopically labelled 
analogues of these compounds are required [17]. Several routes for the synthesis of both racemic and 
chiral 3,4-dibenzyltetrahydrofuran lignan natural products have been reported in the literature. The 
majority of these procedures use Michael additions, dehydration of substituted 1,4-diols, or alkylation 
methodologies. Most of the reported syntheses have been applied for plant lignans burseran (3) and 
dehydroxycubebin (4). 
Figure 1. Naturally occurring 3,4-dibenzyltetrahydrofuran lignans (IUPAC names in 
parentheses). Mammalian lignan enterofuran (1, 3,3′-dihydroxy-9,9′-epoxylignane), and 
plant lignans anhydrosecoisolariciresinol aka shonanin (2, 4,4′-dihydroxy-3,3′-dimethoxy-
9,9′-epoxylignane) [14,18,19], burseran (3, 3,4,5-trimethoxy-3′,4′-methylenedioxy-9,9′-
epoxylignane) [12], dehydroxycubebin (4, (3,4),(3′,4′)-dimethylenedioxy-9,9′-epoxy-
lignane) [20], brassilignan (5, 3,3′,4,4′-tetramethoxy-9,9′-epoxylignane) [21], and 6 
(3,3′,4,4′,5,5′-hexamethoxy-9,9′-epoxylignane) [22] (there is some confusion however 
concerning the structure of compound 6: Fuzzatti et al. have measured a positive value of 
the optical rotation for the isolated trans-3,4-dibenzyltetrahydrofuran lignan, but have 
drawn the structure as that of the (8R,8′R)-enantiomer [22], which in all the other reported 
cases is observed to have a negative value). 
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2. Discussion on the Synthesis of Tetrahydrofuran Lignans 
2.1. Building the Lignan Skeleton to a Furan or a Tetrahydrofuran 
In this review the various ways of synthesising the 3,4-dibenzyltetrahydrofuran lignans are divided 
according to whether the lignan skeleton is built by introducing appropriate substituents directly to a 
furan, a 2,5-dihydro- or a tetrahydrofuran ring, or whether the formation of the tetrahydrofuran ring is 
the last stage in a multistep synthesis. The first synthesis of burseran (3) may be counted as one of the 
former approaches, though it is a unique method utilising the Diels-Alder reaction of a furan and 
acetylenic dione 7 to construct the tetrahydrofuran framework (Scheme 1). Selective hydrogenation 
and a retro-Diels-Alder pyrolysis led to a mixture of cis and trans isomers of racemic burseran (3) [23]. 
Scheme 1. The first synthesis of burseran (3). 
 
Reagents and conditions: (a) ethyne, EtMgBr, THF; (b) Ar2CHO, EtMgBr, THF; (c) CrO3, 
acetone; (d) furan, 50 °C; (e) Pd/BaSO4 (H2), EtOAc; (f) 200–250 °C, 0.1 mm; (g) Pd/BaSO4 (H2), 
AcOH. Ar1 = 3,4-methylenedioxyphenyl; Ar2 = 3,4,5-trimethoxyphenyl. 
Rehnberg’s and Magnusson’s approach involved the diastereospecific Michael addition of a 
dithioacetal to a chiral dihydrofuran ketone (8, Scheme 2) as the key reaction step [24].  
Scheme 2. Enantiopure lignans by conjugate addition of dithioacetals to chiral dihydrofuran ketones. 
 
Reagents and conditions: (a) Ar1MgBr, THF; (b) CrO3, CH2Cl2; (c) (PhS)2CHAr, BuLi, THF,  
−78 °C; (d) Raney-Ni, CH3OCH2CH2OCH3, 0 °C; (e) CH3COOH, Pd/C, H2 (1 atm).  
Ar1 = 3,4-methylenedioxyphenyl; Ar2 = 3,4,5-trimethoxyphenyl. 
The benzyloxy-substituted starting material 9 is prepared in 15%–20% overall yield over six 
reaction steps, starting with D- (and L-)-arabinose. The 3,4-trans-stereochemistry is established during 
the Michael addition, when the benzyloxy group forces the nucleophile to an anti-attack, and the steric 
bulk of the aryldithiane moiety in turn forces the aryl ketone moiety into a trans relationship. The 
desulfurized products were submitted to hydrogenolysis over palladium on carbon, to yield variously 
oxygenated tetrahydrofurans depending on the reaction conditions used. The phenyl ketone moiety was 
reduced to a benzylic group in both acidic and basic media. When reductions were performed in acidic 
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media, the fully reduced tetrahydrofurans burseran (3) and dehydroxycubebin (4) were obtained, 
whereas in neutral or basic media the hemiacetals trichostin and cubebin were the products. 
Gaboury and Sibi’s synthesis of racemic [25] or enantiopure [26] tetrahydrofuran lignans begins 
with the cycloaddition of a nitrile oxide to 2,5-dihydrofuran (Scheme 3). After reduction and 
tosylation, the other benzyl substituent is introduced to the furan ring via an SN2 displacement. A 
lipase-mediated kinetic resolution of the alcoholic intermediates 10 furnished both enantiomers of the 
lignan precursors in high optical purity and enabled the subsequent synthesis of pure enantiomers [26]. 
Scheme 3. Intermolecular nitrile oxide cycloaddition to 2,5-dihydrofuran. 
 
Reagents and conditions: (a) Ar1CNO (generated in situ); (b) Raney-Ni/H2, B(OH)3; (c) 10% Pd/C, 
H2 (3 atm), HCl; (d) MeLi, TsCl; (e) n-BuLi, PhSCH2Ar, 0 °C to rt, Ar = Ar1 (57%),  
Ar = Ar2 (72%); (f) Raney-Ni, EtOH, reflux, (4, 97%; 3, 96%). Ar1 = 3,4-methylenedioxyphenyl;  
Ar2 = 3,4,5-trimethoxyphenyl. 
Another approach to synthesise tetrahydrofuran lignans was reported by Hanessian and Léger [27]. 
Radical-mediated carbocyclisation of a diene, obtained from a substituted cinnamyl alcohol, gave a 
tetrahydrofuran derivative (Scheme 4). Destannylation and epimerization of the aldehyde intermediate 
with DBU gave the trans enriched isomer. Further reactions on this aldehyde furnished racemic 
burseran (3) and dehydroxycubebin (4). Esterification of the preceding alcohols with (S)-O-methyl 
mandelic acid gave the corresponding esters which were separable by column chromatography into 
their diastereomers and hydrolysed to pure enantiomers. 
Scheme 4. Synthesis of burseran (3) and dehydroxycubebin (4) via radical mediated carbocyclisation. 
 
Reagents and conditions: (a) NaH, CH2=CHCH2Br; (b) Me3SnCl, NaBH3CN, AlBN; (c) CAN  
(2 eq.), MeOH, slow addition, 2 h; (d) DBU, CH2Cl2; (e) LiAr1; (f) 1. Ac2O, Et3N, DMAP; 2. H2, 
Pd/C (10%). Ar1 = 3,4-methylenedioxyphenyl, Ar2 = 3,4,5-trimethoxyphenyl. 
As a part of developing new strategies for the synthesis of heterocyclic structures, Garçon et al. 
reported a one-pot synthesis of 4-benzyl-3-carboxylate furans and their use as tetrahydrofuran lignan 
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precursors (Scheme 5) [28]. The lignan skeleton was finally achieved with Hanessian’s and Léger’s 
procedure [27]. 
Scheme 5. Synthesis of burseran (3) via 3-benzylfuran. 
 
Reagents and conditions: (a) LiAlH4, THF, rt.; (b) Raney-Ni, H2 (10 bars), THF, rt; (c) (COCl)2, 
DMSO, CH2Cl2, −78 °C to rt. (90%); (d) DBU, CH2Cl2, rt (quant.). Ar2 = 3,4,5-trimethoxyphenyl. 
2.2. Cyclisation of a 1,4-Butanediol to a Tetrahydrofuran 
Derivatising is a useful way to study and characterise natural products. Several groups have 
converted a lactone lignan natural product to a tetrahydrofuran lignan. The lactone is reduced to a  
1,4-butanediol, in most cases with lithium aluminum hydride, followed by dehydration to the 
tetrahydrofuran lignan. Dehydration is usually carried out either under acidic conditions or by 
elimination of a tosylate in pyridine. 
Haworth and coworkers used potassium hydrogen sulfate to convert substituted 1,4-butanediols to 
tetrahydrofuran derivatives. The diol was heated with potassium hydrogen sulfate at 180 °C for 0.5 h [29,30]. 
Eich et al. isolated the trans-dibenzylbutyrolactone type lignans (−)-matairesinol and (−)-arctigenin 
from a Forsythia species, converted the lactone to the corresponding diols with LiBH4 and further to 
tetrahydrofurans by treatment with p-toluenesulfonic acid in dichloromethane [31]. 
Structure elucidation of a natural product lignan was performed by synthesising 
anhydrosecoisolariciresinol (2) via the Stobbe procedure [8]. The diol secoisolariciresinol (11) (Scheme 6), 
formed after condensations, hydrogenation, debenzylation and reduction, was treated with p-tosyl 
chloride to give the tetrahydrofuran lignan anhydrosecoisolariciresinol (2). Matsuura et al. reported no 
other products than the racemic diol 11 and further the tetrahydrofuran (±)-2 [8]. In contrast, when  
Xia et al. exploited the Stobbe procedure in their total synthesis of ferulate derivatised 
anhydrosecoisolariciresinol, they performed the hydrogenation and deprotection steps in a different 
order and achieved a 1:1 mixture of meso- and (±)-secoisolariciresinol (11) (Scheme 6) [32]. 
Stobbe condensation was also the first step in the procedure of Coran et al. [33], but they used two 
equivalents of the starting material to get a fulgenic acid 13 (Scheme 7). Catalytic hydrogenation of 13 
yielded a mixture of trans- and cis-dibenzylbutyrolactone lignans, which was trans enriched in 
methanolic potassium hydroxide solution [34]. Their first approach to a tetrahydrofuran structure was 
via the corresponding diol, from the usual LiAlH4 reduction, which was dehydrated with Al2O3 to 
cause ring closure to the tetrahydrofuran. However, they improved the route with an autoclave 
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procedure, where the lactones were hydrogenated with a copper chromite catalyst to the diols, which 
were concomitantly dehydrated to tetrahydrofurans in one step (f in Scheme 7) [33]. 
Scheme 6. Synthesis of the lignan skeleton via Stobbe condensation and standard reduction. 
 
Reagents and conditions: (a) Na, EtOH, reflux.; (b) Me2SO4, K2CO3, DMF; (c) 12; (d) MeI, K2CO3, 
DMF; (e) H2, Pd/C (10%) ; (f) LiAlH4; g) p-TsCl; (h) LiAlH4/AlCl3; (i) BnCl, EtOH, K2CO3.  
Ar3 = 4-hydroxy-3-methoxyphenyl, Ar4 = 4-benzyloxy-3-methoxyphenyl. 
Scheme 7. Stobbe condensation, and a one step autoclave procedure from lignano-9,9′-
lactones to corresponding 9,9′-epoxylignans. 
 
Reagents and conditions: (a) NaH, toluene, reflux, 2–12 h; (b) H2, Ru4H4(CO)8(PBu3)4, 230–280 bar, 
180 °C, 48 h; (c) 1% KOH/MeOH, 48 h; (d) LiAlH4, THF, reflux, 75 min; (e) Al2O3, toluene, 
reflux, 2.5 h; (f) H2, Al2O3, 2 CuO.Cr2O3, toluene, 340 bar, 230 °C, 30–35 h. Ar2 = 3,4,5-
trimethoxyphenyl, Ar5 = 3,4-dimethoxyphenyl, Ar6 = 3-methoxyphenyl. 
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The stereoselective total synthesis of optically active trans- and cis-burserans by Tomioka et al. 
started with the alkylation of a chiral piperonyl substituted γ-butyrolactone 18. The formed lignano-
9,9′-lactones were reduced to corresponding diols [35,36]. The synthesis of (−)-trans-burseran (3) is 
shown in Scheme 8. 
Scheme 8. Stereoselective synthesis of burseran (3) from a chiral γ-butyrolactone. 
 
Reagents and conditions: (a) LDA, HMPA, Ar2CH2Br, THF, −78 °C; (b) LiAlH4, THF, rt;  
(c) p-TsCl, pyridine, rt 4 h, reflux 3 h. Ar1 = 3,4-methylenedioxyphenyl, Ar2 = 3,4,5-trimethoxyphenyl. 
The work of Tomioka et al. [35,37] was used as a starting point also in the synthesis of optically 
active anhydrosecoisolariciresinol ((−)-2) by Yamauchi et al. [9] (Scheme 9). An optically active 
starting material, the γ-butyrolactone 19 was synthesised from L-glutamic acid [37], and benzylated on 
the α-position. The lactone was reduced, and the corresponding diol was subjected to cleavage of the 
trityl ether under acidic conditions to give a triol. The glycol part was oxidatively cleaved, and a new 
lactone ring was formed via PCC oxidation. Tomioka et al. alkylated the benzylsubstituted lactone  
(+)-18 with benzyl bromide (Scheme 8), while Yamauchi et al. used benzaldehyde 12 for their analog 
(−)-20 (Scheme 9). This caused extra steps to the total synthesis of anhydrosecoisolariciresinol ((−)-2), 
but enabled an access to various hydroxybenzyl derivatives [9]. The enantiomer (+)-2 was synthesised 
analogously starting with D-glutamic acid, and also the synthesis of the meso-isomer of 
anhydrosecoisolariciresinol (meso-2) starting from the acylated oxazolidinone 21 (Scheme 10) was 
reported [11]. 
Scheme 9. Synthesis of enantiopure anhydrosecoisolariciresinol (2) via hydroxybenzyl derivatives. 
 
Reagents and conditions: (a) LDA, Ar4CH2Br, THF, −70 °C, 1 h; (b) (i) LiAlH4, THF, rt. 30 min; 
(ii) conc. HCl, EtOH, rt, 1.5 h; (c) (i) NaIO4, MeOH, rt. 3 h; (ii) PCC, CH2Cl2, rt, 16 h;  
(d) KHMDS, 12, THF, −70 °C, 1 h; (e) TIPSOTf, 2,6-lutidine, CH2Cl2, 0 °C, 1.5 h; (f) LiAlH4, 
THF, rt, 30 min; (g) p-TsCl, pyridine, CH2Cl2, rt, 21 h; (h) (n-Bu)4NF, THF, rt, 1 h; (i) H2, 
Pd(OH)2, EtOAc, rt, 22 h. Ar3 = 4-hydroxy-3-methoxyphenyl, Ar4 = 4-benzyloxy-3-methoxyphenyl. 
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Scheme 10. Synthesis of meso-anhydrosecoisolariciresinol (2) from an N-acylated oxazolidinone. 
 
Reagents and conditions: (a) (i) 12, MgCl2, Et3N, Me3SiCl, EtOAc, rt, 1 h; (ii) CF3COOH, MeOH, 
rt, 1 h; (b) TIPSOTf, 2,6-lutidine, CH2Cl2, 0 °C, 1.5 h; (c) LiBH4, MeOH, THF, rt, 16 h; (d) PivCl, 
pyridine, CH2Cl2, rt, 2 h; (e) (i) OsO4, NMO, aq. acetone, t-BuOH, rt, 16 h; (ii) NaIO4, MeOH, rt,  
1 h; (f) (i) (n-Bu)4NF, THF, 0 °C, 1 h; (ii) PCC, MS 4A, CH2Cl2, rt, 16 h; (g) KHMDS, 12, THF,  
−75 °C, 1 h; (h) Et3SiH, BF3.OEt2, CH2Cl2, 3 °C, 2h; (i) (i) LiAlH4, THF, rt, 30 min; (ii) N-TsIm, 
NaH, –20 °C; (j) H2, Pd(OH)2/C (20%), THF, rt, 16 h. Ar3 = 4-hydroxy-3-methoxyphenyl,  
Ar4 = 4-benzyloxy-3-methoxyphenyl. 
Dianion coupling was the starting point when Belletire et al. synthesised racemic burseran ((±)-3). 
Reaction of the dianion of hydrocinnamic acid with an iodo-substituted carboxylate in the presence of 
a copper(I) salt forms a succinic acid 22. The mixture of diacid diastereomers 22 (Scheme 11) was 
heated at reflux with a large excess of Ac2O, which smoothly epimerized the substituted benzyl chains 
into the thermodynamically more stable trans isomer with concomitant cyclisation to an  
anhydride, which was reduced to a diol [38]. In Tomioka’s et al. [35,36], Yamauchi’s et al. [9] and  
Belletire’s et al. [38] approaches, the 1,4-butanediols formed were cyclised to tetrahydrofurans by 
stirring with p-toluenesulfonyl chloride in pyridine. 
Scheme 11. Racemic burseran (3) by dianion coupling. 
 
Reagents and conditions: (a) NaH; (b) LDA; (c) CuSCN or CuI; H+; (d) Ac2O; (e) LiAlH4;  
(f) p-TsCl, pyridine. Ar1 = 3,4-methylenedioxyphenyl, Ar2 = 3,4,5-trimethoxy-phenyl. 
In the most recent studies the conversion of 1,4-butanediols to tetrahydrofuran lignans is made by 
refluxing in methanolic HCl for several hours [39–42]. Kise et al. obtained the lignan skeleton by 
oxidative homocoupling of optically active hydrocinnamic acid derivatives to a mixture of R,R- and 
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R,S-dimers, which were separated by column chromatography and hydrolyzed to give dibenzylsuccinic 
acids and further reduced to trans- and cis-dibenzylbutanediols (from R,R- and R,S-dimers, 
respectively). The trans-dibenzylbutanediol (−)-dihydrocubebin (23) (Scheme 12) obtained was 
transformed to (−)-dehydroxycubebin (4) by the usual procedure of refluxing in methanolic HCl [41]. 
Scheme 12. Asymmetric synthesis of dehydroxycubebin (4) via the oxidative 
homocoupling of a chiral hydrocinnamic acid derivative. 
 
Reagents and conditions: (a) (i) LDA-THF; (ii) Oxidant (TiCl4, PhI(OAc)2 or CuCl2); (b) LiOOH; (c) (i) LDA; 
(ii) Oxidant (TiCl4, PhI(OAc)2, CuCl2 or I2); (d) LiOH; (e) LiAlH4; (f) LiBH4; (g) HCl/MeOH. Ar1 = 3,4-
methylenedioxyphenyl. (*yields with various oxidants; stereospecificity R,R:R,S varied from 74:26 to 92:8). 
A regioselective oxidative coupling was also a key step in the procedure of Wang et al. [42]. The  
β–β coupling product was hydrogenated to give a mixture of cis- and trans- isomers (in the ratio 3:2).  
Cleavage of the tert-butyl groups and reduction with LiAlH4 afforded meso- and  
(±)-secoisolariciresinols 11 (Scheme 13) which were refluxed under acidic conditions to give the 
tetrahydrofurans meso- and (±)-anhydrosecoisolariciresinol (2), respectively. 
Scheme 13. Meso- and racemic anhydrosecoisolariciresinols 2 via a regioselective 
oxidative coupling. 
 
Reagents and conditions: (a) K3[Fe(CN)6], KOH, C6H6/H2O, rt, 0.5 h; (b) H2, Pd/C (10%), rt, 24 h; (c) AlCl3, 
C6H6, 50 °C, 1 h (79%); (d) LiAlH4, Et2O, −15 °C, 2 h (85%); (e) HCl, MeOH, reflux, 18 h. Ar3 = 4-hydroxy-
3-methoxyphenyl, Ar7 = 4-hydroxy-3-methoxy-5-tert-butylphenyl. 
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In our laboratory we have been studying a versatile route to synthesise the lignan skeleton from 
readily available starting materials (Scheme 14). The dibenzylbutyrolactone skeleton is prepared by a 
tandem Michael addition–alkylation procedure [43]. The protected dithioacetals are obtained by 
reacting the anion of diphenylthioacetal with 2-butenolide 24 at a low temperature, and the 
intermediates are then alkylated in situ with benzylic bromides. The substituents in the starting 
materials, diphenythioacetals and benzylic bromides, may be different or the same, and free phenols 
must be benzyl protected. Raney nickel treatment provides both desulfurisation and simultaneous 
removal of the benzylic protecting groups. The route is flexible in controlling the relative and absolute 
stereochemistry and the nature of the aryl substituents. The approach in scheme 14 gives a racemic 
mixture of trans substituted lignano-9,9′-lactones. In order to obtain optically pure products the 
protocol can be adjusted and controlled by a chiral Michael acceptor instead of butenolide 24 [44]. 
Scheme 14. One-pot Michael addition–alkylation procedure as the key step in obtaining 
various lignan skeletons. 
 
Reagents and conditions: (a) (i) n-BuLi, THF, −78 °C, (ii) 24, THF, −78 °C; (iii) DMI, benzyl bromide, THF, 
−78 °C; (b) Raney-Ni, EtOH, reflux; (c) LiAlH4, THF, (d) conc. HCl, MW, 40 °C, 30 min. 1: Ar = 3-
hydroxyphenyl; 2: Ar = Ar3 = 4-hydroxy-3-methoxyphenyl; 4: Ar = Ar1 = 3,4-methylenedioxyphenyl;  
5: Ar = Ar5 = 3,4-dimethoxy-phenyl; 25: Ar = phenyl. 
The dibenzylbutyrolactones are further reduced to diols with LiAlH4. The cyclisation of trans-
dibenzyl-1,4-butanediols to trans-3,4-dibenzyltetrahydrofurans is performed with conc. HCl under 
microwave heating in 30 min [45]. Utilising this procedure and the fast and easy cyclisation reaction, 
we have synthesised racemic enterofuran (1), anhydrosecoisolariciresinol (2), dehydroxycubebin (4) 
brassilignan (5), and 9,9′-epoxylignane 25, a tetrahydrofuran lignan framework without any substituents 
on the aromatic rings. In addition, we have promising preliminary results showing that this cyclisation 
method works well also for synthesising the furofuran structures from tetraols. 
3. Feasible Experimental Approaches 
Despite their biological activities the 3,4-dibenzyltetrahydrofuran type lignans have not  
been given much attention. This review compiles reported strategies for the synthesis of  
3,4-dibenzyltetrahydrofuran lignans, biologically active plant and mammalian products. They are all 
total syntheses with different key step strategies, including Diels–Alder, Michael additions, 
alkylations, nitrile oxide cycloadditions, radical cyclisations, dianion or oxidative couplings. Most of 
the procedures were used for racemic products. Different approaches are analysed based on whether 
the lignan skeleton is built onto a tetrahydrofuran ring or whether the formation of the tetrahydrofuran 
ring is the last stage in a multistep synthesis. In the latter cases the final tetrahydrofuran lignan product 
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is formed from a corresponding lignanodiol and often also from lignanolactone, which makes it a 
versatile approach to various lignan structures as needed. 
The procedures that give enantiomerically pure products, Rehnberg’s and Magnusson’s (Scheme 2), 
Tomioka’s et al. (Scheme 8), Yamauchi’s et al. (Scheme 9) and Kise’s et al. (Scheme 12), start with 
chiral starting materials. Rehnberg and Magnusson (Scheme 2), Gaboury and Sibi (Scheme 3), Belletire 
et al. (Scheme 11), and Wähälä et al. (Scheme 14) have diastereomeric control over the reactions 
achieving only trans-products. Kise et al. affect the cis/trans-ratio with changing oxidants, while 
Tomioka et al. and Yamauchi et al. have separate routes for both pure diastereomers. 
Although 3,4-dibenzyltetrahydrofuran lignans are rather simple natural products with only two 
chiral centers, the overall yields of these total syntheses range from moderate (59%) to poor (<6%) 
especially when the entire starting material synthesis is taken into account. Thus no procedure seems to 
clearly stand out above others. The overall yield is highest (59%) in the regioselective coupling of  
Wang et al. (Scheme 13), but the procedure gives a mixture of cis- and trans-products. Belletire et al. 
obtain racemic burseran (3), in 46% total yield from hydrocinnamic acid and iodo-substituted 
carboxylate (Scheme 11), which is a convenient procedure in that (like all the others except the 
oxidative homocouplings and the other Stobbe condensation), the aromatic moieties may be the same 
or differently substituted. The autoclave procedure of Coran et al. (Scheme 7) from butyrolactone 
lignans to tetrahydrofurans in one step is a good application to reduce the number of reaction steps and 
isolation of intermediates. However, there is a definite need for simpler, shorter and more  
step-economical approaches. 
The use of dielectric microwave heating has been utilized in organic synthesis at an increasing rate 
since the pioneer work of Gedye [46] and Giguere [47] in 1986. In spite of having become in frequent 
and common use in laboratory work, microwave techniques have not been reported in the synthesis of 
lignans until very recently (e.g., in the synthesis of trisubstituted furanolignans [48], steganacin and 
steganone derivatives [49], and deuterium labelling [50–52]). In many cases microwave heating has 
been shown to dramatically reduce reaction times and enhance product purities, compared with 
conventional heating methods. In most of the reviewed methods the cyclisation of dibenzyl-1,4-
butanediols to 3,5-dibenzyltetrahydrofurans takes several hours, whereas under microwave heating the 
conversion from diol to tetrahydrofuran is in most cases completed in less than 30 min [45]. 
4. Conclusions 
Different procedures to synthesise both enantiopure and racemic 3,4-dibenzyltetrahydrofuran type 
lignans are reviewed and compared. The total syntheses include different key step strategies and enable 
preparation of various plant or mammalian lignans as well as distinct substitution patterns from the 
known natural ones. However, there is still room for improvement and for simpler and more  
step-economical approaches. 
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